---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-009002"
form_type: "8-K"
ticker: "PTN"
cik: "0000911216"
company_name: "PALATIN TECHNOLOGIES INC"
filed_at: "2023-07-11T23:59:59+00:00"
generated_at: "2026-06-13T10:23:58.549160+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Palatin prelim Q4 Vyleesi net revenue $1.7M, up 122% YoY; prescriptions +89% YoY

## Summary
- Gross product revenue $4.1M, up 20% QoQ and 78% YoY.
- Net product revenue $1.7M, up 42% QoQ and 122% YoY.
- Prescriptions dispensed increased 14% QoQ and 89% YoY.
- New healthcare prescribers up 20% QoQ; 6 consecutive quarters of double-digit growth.
- Management states net revenue per prescription continues to improve, exceeding quarterly operating expenses.

## SEC filing metadata
- accession: 0001654954-23-009002
- form_type: 8-K
- ticker: PTN
- cik: 0000911216
- company_name: PALATIN TECHNOLOGIES INC
- filed_at: 2023-07-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/911216/000165495423009002/0001654954-23-009002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/911216/000165495423009002/ptn_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-009002
- JSON: https://secwatch.observer/filing/0001654954-23-009002.json
- Plain text: https://secwatch.observer/filing/0001654954-23-009002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.